Robert DunnVice President, Head of Global Commercial Finance at QuidelOrthoSpeaker
Bob currently serves as the Vice President of Global Commercial Finance at QuidelOrtho Corporation (QDEL). In this role Bob oversees finance and accounting teams across all major regions and is responsible for driving commercial financial results and strategies related to revenue, EBITDA and cash flow.
Prior to his role current role, Bob served as the enterprise integration lead for Ortho Clinical Diagnostics (OCDX) during it’s merger with Quidel Corporation in May 2022. Prior roles also include Corporate Controller, Ortho Clinical Diagnostics, co-leading Ortho Clinical Diagnostics’ IPO in January 2021 and various other roles across Ortho Clinical Diagnostic and Johnson and Johnson.
Bob graduated from Pennsylvania State University, holds CFA, CPA and CMA designations and enjoys cooking and spending time with his wife and two boys.